Search Results - "McLaughlin, Joseph Francis"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Validation study of end-of-life risk prediction model in active chemotherapy patients

    Validation study of end-of-life risk prediction model in active chemotherapy patients by Hill, Melinda S., Abdo-Matkiwsky, May D., Biran, Noa, Chatiwala, Jumana, Chen, Aileen L., Childs, Julianne Wilkins, Fitzgerald, Denis, Graham, Deena Mary Atieh, Horkheimer, Ian, Levenbach, Rachel L., McLaughlin, Joseph Francis, Salwitz, Kimberly A., Smith, Frederick P., Tassan, Robert F., Ejumejowo, Akunna J.

    Published in Journal of clinical oncology (01-06-2022)
    “…e13543 Background: In February of 2020, Integra Connect (IC) released a machine learning (ML) risk prediction model called Integra Predict (IP) to predict…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Safety, pharmacokinetics (PK), pharmacodynamics (Pd), and antitumor activity in a phase 1b study evaluating anti-ErbB3 antibody KTN3379 in adults with advanced tumors alone and with targeted therapies

    Safety, pharmacokinetics (PK), pharmacodynamics (Pd), and antitumor activity in a phase 1b study evaluating anti-ErbB3 antibody KTN3379 in adults with advanced tumors alone and with targeted therapies by Falchook, Gerald Steven, Bauer, Todd Michael, LoRusso, Patricia, McLaughlin, Joseph Francis, LaVallee, Theresa, Peck, Ronald Alan, Eder, Joseph Paul

    Published in Journal of clinical oncology (20-05-2016)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Clinical significance of TILs subtypes in non-small cell lung cancer

    Clinical significance of TILs subtypes in non-small cell lung cancer by Schalper, Kurt A., Brown, Jason, McLaughlin, Joseph Francis, Herbst, Roy S., Rimm, David L.

    Published in Journal of clinical oncology (20-05-2014)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Significance of PD-L1, IDO-1, and B7-H4 expression in lung cancer

    Significance of PD-L1, IDO-1, and B7-H4 expression in lung cancer by Schalper, Kurt Alex, Carvajal-Hausdorf, Daniel E., McLaughlin, Joseph Francis, Altan, Mehmet, Syrigos, Konstantinos N., Herbst, Roy S., Rimm, David L.

    Published in Journal of clinical oncology (20-05-2015)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Objective measurement and significance of PD-L1, B7-H3, B7-H4 and TILs in small cell lung cancer (SCLC)

    Objective measurement and significance of PD-L1, B7-H3, B7-H4 and TILs in small cell lung cancer (SCLC) by Schalper, Kurt Alex, Carvajal-Hausdorf, Daniel E., McLaughlin, Joseph Francis, Altan, Mehmet, Chiang, Anne C., Velcheti, Vamsidhar, Kaftan, Edward, Zhang, Jie, Lu, Liming, Rimm, David L., Han, Baohui, Lu, Hui, Zhao, Hongyu, Herbst, Roy S.

    Published in Journal of clinical oncology (20-05-2016)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Domain-specific PD-L1 protein measurement in non-small cell lung cancer (NSCLC)

    Domain-specific PD-L1 protein measurement in non-small cell lung cancer (NSCLC) by McLaughlin, Joseph Francis, Schalper, Kurt, Carvajal-Hausdorf, Daniel E., Velcheti, Vamsidhar, Haack, Herbert, Silver, Matthew, Goldberg, Sarah B., Herbst, Roy S., Rimm, David L.

    Published in Journal of clinical oncology (20-05-2014)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: